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Abstract
The hidden Markov model (HMM) has been a workhorse of single molecule data analysis and is now
commonly used as a standalone tool in time series analysis or in conjunction with other analyses methods
such as tracking. Here we provide a conceptual introduction to an important generalization of the HMM
which is poised to have a deep impact across Biophysics: the infinite hidden Markov model (iHMM). As a
modeling tool, iHMMs can analyze sequential data without a priori setting a specific number of states as
required for the traditional (finite) HMM. While the current literature on the iHMM is primarily intended for
audiences in Statistics, the idea is powerful and the iHMM’s breadth in applicability outside Machine Learning
and Data Science warrants a careful exposition. Here we explain the key ideas underlying the iHMM with a
special emphasis on implementation and provide a description of a code we are making freely available. In a
companion article, we provide an important extension of the iHMM to accommodate complications such as
drift.
1 Introduction
Hidden Markov models (HMMs) [1, 2] provide a method for analyzing sequential time series data and have been
a workhorse across fields including Biology [3, 4], Physics [5, 6, 7], and Engineering [8, 9, 10].
The power of HMMs has been heavily exploited in Biophysics [11, 12] in the interpretation of single molecule
experiments such as fluorescence resonance energy transfer (FRET) [13]; force spectroscopy [14]; atomic force
microscopy [15]; and ion channel patch-clamp [16]. The data from these disparate techniques may be analyzed
using HMMs because biomolecules or collections of biomolecules are seen as visiting discrete states and the signal
emitted from each state is corrupted by noise; see Fig. 1.
While HMMs have been hugely successful, the method has encountered a fundamental limitation. That is,
the number of different states visited over the course of an experiment must be specified in advance [13]. This
limitation is too restrictive for complex biomolecules where state numbers may often be difficult to assess a priori.
It also presents a problem when the number of states appears to vary from trace to trace as would be expected if
some states are only rarely visited. As a work-around, problem- and user-dependent pre- or post-processing steps
have therefore been suggested in the biophysical literature to winnow down the number of candidate models or
eliminate problematic traces altogether. Popular choices include model-selection tools such as information criteria
(e.g. BIC, AIC [11, 17]) or maximum evidence methods (e.g. [12]). However, thanks to recent Mathematics –
Bayesian nonparametrics, first introduced in 1973 [18] – an elegant solution is available that largely circumvents
these model selection steps.
In this perspectives article, we provide a description of the concepts and implementation of an important
new computational tool that exploits Bayesian nonparametrics: the infinite HMM (iHMM) that was heuristically
described in Ref. [19] but only fully realized in 2012 [20].
It has recently been suggested that Bayesian nonparametrics are poised to have a deep impact in Biophysics [21]
and, in this field, they have just begun to be exploited [22, 23, 24]. However, there is – to our knowledge – no
single resource yet available describing the iHMM, its concepts or implementation, as would be required to bring
the power of Bayesian nonparametrics to bear on Biophysics and accelerate its inevitable widespread adoption.
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Figure 1: A synthetic time trace illustrating measurments of a hypothetical biomolecule that undergoes confor-
mational transitions. Left: the state space consists of conformations depicted discretely as σ1, σ2, . . . . Middle: time
series of noisy observations xn produced by the biomolecule (blue) and corresponding noiseless trace (red). Over the time
course of the measurements, the biomolecule attains only conformations σ1–σ5, though additional conformations might be
visited at subsequent times. For sake of concreteness only, we label these states in order of appearance from 1 through 5.
Right: binning the collected observations reveals “emission distributions” Fσk associated with each conformation. These
distributions are highlighted with red lines. The centers (mean values) of the emission distributions are used to obtain the
noiseless trace in the middle panel. The illustration on the left is created using data from Ref. [25].
Indeed, while the iHMM tackles a conceptually simple problem, it relies on Mathematics whose literature is
inaccessible outside a rarified community of Statisticians and Computer Scientists.
It is for this reason that we have organized our perspective article as follows: Section 2.1 describes the
structure of the HMM in its finite (traditional) and infinite (nonparametric) realizations; Section 2.2 presents a
computational algorithm to perform inference with the iHMM that we make freely available; Section 3 shows
results from sample time traces; and Section 4 discusses the potential for further applications to Biophysics.
2 Methods
2.1 Formulation of the iHMM
Here we introduce the HMM and its generalization, the iHMM. To facilitate the presentation, we initially describe
the structure of the space within which the biomolecule evolves and subsequently formulate the dynamics. This
discussion applies to both HMMs and iHMMs.
In the HMM framework, a system of interest is assumed to alternate successively between different states
labeled σk where k takes integer values from 1 to some L. We use L to denote the total number of states
available to the system, no matter if all these states are visited or some remain unvisited during the time course
of the measurements. For instance, for an experiment on a single protein, the protein is the “system” and the
“states” are conformations such as open/closed conformations of an ion channel [16] or low/high efficiency states
in FRET experiments [26]. For an illustration see Fig. 1 (left).
In the standard HMM, we assume that the system’s transitions are governed by Markovian dynamics [1]. This
means that the system jumps from a state σk to a state σj , for example from one FRET value to another, in a
stochastic manner that depends exclusively on σk and not any other state visited in the past. For this reason, all
transitions out of state σk are fully described by a probability vector p˜iσk = (piσk→σ1 , piσk→σ2 , . . . ), where piσk→σj
is the probability of departing from state σk and arriving to σj .
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A note on our notation is appropriate here. Throughout this survey we adopt tildes to denote vectors with
components over S, the system’s state space {σ1, σ2, . . . }, such as p˜iσk . Shortly, we will adopt bars to denote
vectors with components over time.
Once the system reaches a state σk, observations are emitted stochastically according to a probability distri-
bution unique to σk; see Fig. 1 (right). We call this the “emission distribution” Fσk . It is often practical to model
the emission distributions by a general family and use state-specific parameters φσk to distinguish its members.
For example, to model Gaussian emissions x, as in Fig. 1, we may choose
Fσk(x) =
1
σσk
√
2pi
exp
(
− (x− µσk)
2
2σ2σk
)
(1)
where φσk = (µσk , σσk) stands for the mean µσk and standard deviation (width) σσk of the observations produced
by state σk. There, for example, we define φσ1 = (µσ1 , σσ1), φσ2 = (µσ2 , σσ2), etc, where (µσ1 , µσ2 , ...) are the
state FRET efficiencies and (σσ2 , σσ2 , ...) are the corresponding spreads attributed to noise.
Next, we let sn denote the state of the system at the nth time step of the experiment and xn its corresponding
observation. Thus, we label with n the states of the system as it evolves through time forming a sequence
s1 → s2 → · · · → sN , with each sn being equal to some state σk chosen from S. For completeness, we may
also assume that, before the first measurement, the system is at a default state which we denote as s0. Again,
we mention that S might contain states that do not appear in this sequence, i.e. states that remain unvisited
throught the experimental time course.
As is it common in the statistical literature – and especially since we will borrow from this notation to introduce
the iHMM – we express the HMM compactly using the following scheme
sn
∣∣sn−1 ∼ CatS(p˜isn−1) (2)
xn
∣∣sn ∼ Fsn (3)
and depict it schematically in Fig. 2. The notation “∼” we use above indicates that the random variables on the
left side are distributed according to, and therefore sampled from, the probability distributions shown on the right
side [27]. For example, Eq. (2) denotes a sampling from a categorical probability distribution that is supported
on S, i.e. sn equals a state σk that is taken from S with probability pisn−1→σk .
As can be seen from Eqs. (2) and (3), the HMM models the experimental output in a doubly stochastic
manner: i) the state of the system sn evolves stochastically within S, as expressed by Eq. (2); and ii) the
observations xn from each sn are also emitted stochastically, as expressed by Eq. (3). In particular, for single
molecule experiments, these two characteristics allow the HMM to elegantly capture: i) the seemingly random
biomolecular state switching; and ii) the noise corrupting the measurements [13, 28].
From the experimental measurements, we gain access only to the observations xn, which take the form of a
time series x¯ = (x1, x2, . . . , xN ) over some regularly spaced time intervals tn. In the most general case, the goals
of the HMM are to estimate: i) the underlying state sequence s¯ = (s1, s2, . . . , sN ) which is unobserved during
the measurements; and ii) the model parameters which include φσk of the emission distributions and the state
transition probabilities piσk→σj associated with the states in S. Of course, in practice these goals are feasible only
for those states that are visited during the experimental time course.
Normally, this is the extent of the HMM. That is, one fixes L, i.e. the size of the state space S, writes down
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Figure 2: Graphical representation of the HMM. In the HMM, a biomolecule of interest transitions between unobserved
states sn according to the probability vectors p˜isn and generates observations xn according to the probability distributions
Fsn that depend on parameters φsn . Here, following convention, the xn’s are shaded to denote that these quantities are
observed, while the sn’s are hidden. Arrows denote the dependences among the model variables and red lines denote the
model parameters.
the likelihood of observing the sequence of observations x¯ = (x1, x2, . . . , xN ), and maximizes this likelihood to
estimate the quantities of interest. Extensive literature – that has made its way into standard textbooks, for
example Ref. [27] – explain each of these steps in detail.
However, in preparation for the iHMM, we take a Bayesian route to accomplish the goals of the HMM [21].
This is a computational overkill for some applications but otherwise essential to its nonparametric generalization.
Following the Bayesian paradigm [21, 29], we assign prior probabilities to model parameters including the
emission parameters φσk and transition probability vectors p˜iσk . For instance, we may assume a prior φσk ∼ H
given by a common distribution for all states. However, assigning a prior to p˜iσk is more subtle as any choice must
ensure that the predicted transitions stay within the system’s state space S. It is specifically the formulation of
this prior that fundamentally distinguishes the finite from the infinite variants of the HMM [20], both of which
we describe next.
In the finite variant of the HMM [1, 2], before setting the prior on p˜iσk , we must fix L, the total number of
states in S or, in the language of single molecule Biophysics, conformations available to the biomolecule. Once L
is fixed, the symmetric Dirichlet distribution is a common choice
p˜iσk ∼ DirS
(α
L
, . . . ,
α
L
)
. (4)
Here, DirS(α/L, . . . , α/L) denotes the Dirichlet distribution supported on S with concentration parameter α (for
an explicit definition of the Dirichlet distribution see supporting material). Basically, this prior asserts that lacking
any information on the system’s kinetics, the model is likely to place on average equal probability on any possible
transition σk → σj . In this prior, the value of α can be used to influence the transitions departing each state.
For example, with α  1 the prior tends to favor uniform transitions, while with α  1 the prior tends to favor
sparse transitions. In other words, the resulting sequence s¯ tends to contain several different states for α  1,
while it tends to contain fewer for α 1.
The Dirichlet prior in Eq. (4) offers two key advantages: i) it provides a non-informative prior since no specific
transitions between the L states are preferentially selected; and ii) it combines well with (i.e. is conjugate to) the
categorical distribution of Eq. (2) which greatly simplifies model parameter estimation.
Although such priors help lessen the computational burden, pre-setting L: i) ignores the data and thus the
arbitrary choice of L may cause under- or over-fitting that, in turn, has far-reaching consequences in estimating
state kinetics; and ii) does not allow the model’s complexity to grow in response to newly available data (e.g. a
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Figure 3: Graphical representation of the iHMM. The hidden Markov model that formulates the observations to be
analyzed (black lines) is shown together with its priors (red lines). For completeness, we also show the concentration
parameters α, γ and the prior probability distribution on the emission parameters H that fully characterize the iHMM.
The key difference from the HMM shown in Fig. 2 is that now the model parameters p˜iσk and φσk are treated as random
variables similar to the hidden states sn and observations xn. For details see the main text.
rare state visited later or in another time series). Resolving issue ii) in a principled fashion can also help avoid
cherry-picking data sets behaving closer to one’s expected or preferred value of L. It is to resolve such issues that
the iHMM has been developed in the first place.
Now, in the infinite HMM, the key difference is that S is assumed infinite in size [19]. To avoid any confusion,
we point out that this assumption is different from forcing the system to visit an infinite number of states, as
it might appear at first. Regardless of the size of S, the system visits only K different states, where K cannot
exceed, for example, the number of steps N in the collected time series. In practice, of course, we expect K to
be considerably smaller than N .
As we will see, with an infinite state space, the iHMM can recruit as many states as necessary and, in doing
so, avoids underfitting by growing the state space as new states are visited (through the effect of the prior) but
also avoids overfitting by placing more weight on states already visited (through the effect of the likelihood).
The generalization of the Dirichlet distribution appropriate for the infinite sized S is the Dirichlet process
p˜iσk ∼ DPS(α, β˜) (5)
where β˜ is the “base distribution” of the Dirichlet process (DP) which determines how p˜iσk are distributed on
average. The notion of a base is only required for the infinite DP and has no direct analog in the finite Dirichlet
distribution. By contrast, α is similar to the concentration of the finite HMM since it controls the sparsity of the
transition probability vectors p˜iσk . For instance, large values of α make the model more likely to choose p˜iσk that
are similar for all states, while low values of α make the model more likely to choose p˜iσk that differ considerably.
The DP is at the basis of much of nonparametric Bayesian inference. It was only in 2012 that a hierarchical
DP (HDP) was invoked in order to construct the iHMM [20]. The basic idea is to select a random – albeit discrete
– base distribution β˜ = (βσ1 , βσ2 , . . . ), with members βσk that: i) are infinite in number, ii) attain non-negative
values, and iii) sum to 1. In the HDP, it is common to sample such a base from a GEM (Griffiths-Engen-McCloskey)
distribution realized through a stick-breaking construction [30, 20, 31]
β˜ ∼ GEMS(γ). (6)
which ensures all these properties. Intuitively, the stick-breaking above is obtained as follows: we start with a
stick of length 1. We break the stick at some location v1 and use the broken fraction for the probability of visiting
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σ1, thus βσ1 = v1. Subsequently, we break the remaining stick at v2 and use that new fraction for the probability
of visiting σ2, thus βσ2 = v2(1 − βσ1), and so on. In this stick-breaking, the locations vk are sampled from a
beta distribution B(1, γ), so γ determines the relative location of the break point. Thus γ can be used to set how
rapidly βσk decreases toward zero and ultimately controls the number of states in S with an appreciable weight
of being visited at least once during the experiment.
In summary, the iHMM – together with its priors illustrated in Fig. 3 – takes the following form
β˜ ∼ GEMS(γ) (7)
p˜iσk
∣∣β˜ ∼ DPS(α, β˜) (8)
φσk ∼ H (9)
sn
∣∣sn−1, ˜˜pi ∼ CatS(p˜isn−1) (10)
xn
∣∣sn, φ˜ ∼ Fsn (11)
where, for notational simplicity, we use ˜˜pi = {p˜iσ1 , p˜iσ2 , . . . } and φ˜ = {φσ1 , φσ2 , . . . } to gather the transition
probability vectors and emission parameters associated with all states in S. Here, ˜˜pi can be seen as a bi-infinite
matrix whose elements are the probabilities for each possible transition σk → σj and it is directly analogous to
the transition matrix of the finite HMM.
Unlike the finite HMM where we need to be specific about the size of the state space, the iHMM gives us
greater flexibility through the hyperparameters α and γ. For instance, larger concentrations are more appropriate
for biomolecules with roughly similar transition rates and several conformations while low concentrations are more
appropriate for biomolecules with dissimilar transition rates and few conformations. In general, it is possible to
sum over these concentrations if we are truly ignorant of the properties of the biomolecule at hand [20, 32].
As we will see shortly, this powerful formalism allows us to infer state numbers robustly and, even if the
number of states is apparent – something which is rarely the case for more complex problems [33] – avoids the
critical shortfall of cherry-picking data sets to be analyzed that appear to have similar state numbers.
2.2 Inference on the iHMM
Prior to describing the analysis that iHMMs may offer, we show how to infer quantities such as the hidden state
sequence and the parameters from the experimental traces. A working implementation of the algorithm described
in this section, equipped with a user interface, can be found in the supporting materials.1
To be clear, on account of the infinite size of S, common methods used in finite state HMMs such as
Expectation-Maximization or simply EM [1] are inapplicable. Instead, we focus our discussion on a specialized
method: the beam sampler [34]. Other methods are also described elsewhere [20, 32].
The beam sampler is a special instance of the Gibbs sampler [35], and although it is beyond the scope of this
survey, a brief description about its usage might be beneficial here. Similar to all samplers of this family, we use
the beam sampler to generate (pseudo) random sequences of the model variables we are interested in inferring.
Specifically, in our case these variables consist of the hidden state sequence s¯ and the model parameters β˜, ˜˜pi, φ˜.
When generating the sequences, we use Eqs. (7)–(11) and the data x¯. As a result, the generated sequences have
the same statistical properties as if they were consisting of samples from the posterior probability distribution
1This code can also be found on the authors’ website as well as on GitHub.
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P(s¯, β˜, ˜˜pi, φ˜|x¯). So, we may use them to compute averages, confidence intervals, maximum a posteriori estimates,
or simply produce histograms that resemble P(s¯, β˜, ˜˜pi, φ˜|x¯) as we show in the next section.
Overall, Gibbs and related samplers provide a more general approach than, for example, EM which provides
only the maximum of P(s¯, β˜, ˜˜pi, φ˜|x¯). Instead, with Gibbs sampling, we fully characterize P(s¯, β˜, ˜˜pi, φ˜|x¯) over its
whole domain. For an introduction to the general methodology underlying Gibbs sampling we refer the interested
reader to Ref. [36], while from now on we focus on the iHMM.
Suppose we have a time series of experimental observations x¯. Here we describe the steps involved in generating
samples (superscripted r) of our model variables s¯(r), β˜(r), ˜˜pi(r), φ˜(r). Given a computed sample (r−1), the naive
approach for computing the next one would be by updating each of the involved variables conditioned on the other
variables and the data [36]. For example, we could generate s¯(r) by sampling from P(s¯|β˜(r−1), ˜˜pi(r−1), φ˜(r−1), x¯).
Then, we could generate β˜(r) by sampling from P(β˜|s¯(r), ˜˜pi(r−1), φ˜(r−1), x¯), and so on. From the theory of Markov
chain Monte Carlo sampling – for example Ref. [35] – this approach is guaranteed to produce samples from the
full posterior P(s¯, β˜, ˜˜pi, φ˜|x¯) as we wish. However, the infinite size of S makes this approach impractical since in
each iteration we need to sample infinite sized β˜, ˜˜pi, φ˜ which is computationally infeasible.
It is fundamentally because of this difficulty that we need the beam sampler which introduces a set of auxiliary
variables (slicers) that in each iteration effectively truncate S to a finite portion [34, 37]. In particular, for each
time step n in the dataset consider an auxiliary variable un and let u¯ = (u1, u2, . . . , uN ) gather all of them. Since
u¯ consists of auxiliary variables only, we have
P
(
s¯, β˜, ˜˜pi, φ˜
∣∣x¯) = ∑
u¯
P
(
u¯, s¯, β˜, ˜˜pi, φ˜
∣∣x¯) (12)
where the sum on the right hand side is considered over all possible values u¯ may take. Now, we can use the
equality in Eq. (12) to sample from P
(
u¯, s¯, β˜, ˜˜pi, φ˜
∣∣x¯) instead from P (s¯, β˜, ˜˜pi, φ˜∣∣x¯). The benefit of doing so is
that, when updating β˜, ˜˜pi, φ˜, we have to sample conditioned also on u¯. Thus, by properly choosing the auxiliaries
un, we make these updates consider only a finite selection of the states σk. For instance, by having un uniformly
distributed over the interval (0, pisn−1→sn), it is sufficient to consider only those σk in S that have a probability
of being visited at least once that is greater than un. Therefore, we can generate the desired samples while
maintaining a finite S that we expand and compress dynamically according to u¯.
In summary, given s¯(r−1), β˜(r−1), ˜˜pi(r−1), and φ˜(r−1) the beam sampler generates a new set of samples
through the following steps:
1. Generate u¯(r) by sampling from P(u¯|s¯(r−1), ˜˜pi(r−1))
2. Expand S according to u¯(r)
3. Generate s¯(r) by sampling from P(s¯|u¯(r), ˜˜pi(r−1), φ˜(r−1), x¯)
4. Compress S according to s¯(r)
5. Generate β˜(r) by sampling from P(β˜|β˜(r−1), s¯(r))
6. Generate ˜˜pi(r) by sampling from P(˜˜pi|s¯(r), β˜(r))
7. Generate φ˜(r) by sampling from P(φ˜|s¯(r), x¯)
7
where for simplicity we have dropped additional dependencies in the conditional probability distributions above.
In principle, β˜, ˜˜pi, and φ˜ are infinite dimensional vectors. However, as mentioned above, the sampler requires
the computation of only those components that correspond to the states which u¯ allows to be visited. Therefore, in
step 4 of the above algorithm we can safely discard those components that are absent from the state sequence s¯(r).
By doing so, in each time, we only need to store vectors of finite dimension, β˜(r), ˜˜pi(r), and φ˜(r). Subsequently, in
step 2 of the following iteration we can supplement β˜(r), ˜˜pi(r), and φ˜(r) with states as necessary. The discarded
states, since are unvisited, do not produce any of the observations in x¯. Thus, they do not provide any information
that could be lost. Similarly, the supplemented states are also not associated with any of the observations in x¯.
Thus, when we generate them, we simply have to draw samples from their priors. Consequently, the supplemented
states neither require nor introduce extra information as it might appear at first. In summary, expanding and
compressing S in steps 2 and 4 leaves our inference unaffected.
The supporting materials provide a pseudocode implementation of the algorithm with further details on each
of the sampler’s steps for the interested reader.
3 Results
In this section, we demonstrate the use of the iHMM in the analysis of time series data. To benchmark the method,
we use synthetic time series where the “ground truth” is known. In a companion Research article – that draws
heavily from the formulation described in this paper – we show the performance of the method on actual time
traces that exhibit further complications such as drift [38]. For such time traces, we need an additional important
generalization to the iHMM; the iHMM must be coupled to a continuous process. For now, our synthetic traces
are meant to illustrate realistic data with noise but from which drift is otherwise absent or minimal.
Below we present the results of the analysis on two types of time traces specifically problematic for the HMM:
• Dataset 1: time traces where the visited states are in high number and their emissions show significant
overlap.
• Dataset 2: time traces where some states are rarely visited and the number of states appears to change as
more data become available.
Details about the generation of these datasets, as well as more in depth analyses than those we discuss here, can
be found in the supporting materials.
The datasets we analyze are shown in Fig. 4. Specifically, we used these time series to estimate the posterior
distributions over: i) the number, K, of different conformations visited by the biomolecule, and ii) the parameters
describing the emission distributions, such as the mean value for each conformation µσk , for those states. To
accomplish this, we generate samples from P(u¯, s¯, β˜, ˜˜pi, φ˜|x¯) using the beam sampler described earlier.
Figure 5 shows how the number of different states visited in each sampled state sequence s¯(r) for dataset 1,
which we denote with K(r), changes through the sampler’s iterations. Again, we mention that K counts only
those states that are visited within the given trace. Initially, K(1) equals the number of states in the state space
as specified in the initialization of our method. After approximately 50 iterations, K(r) drops to 5 which is the
correct number of states attained by our hypothetical biomolecule.
Subsequently, K(r) stays at 5 and occasionally adds extra states that are rapidly eliminated. This behavior is
characteristic of our algorithm [35]. In the initial iterations, known as “burn-in”, the sampler randomly explores
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Figure 4: Synthetic datasets resembling a hypothetical biomolecule undergoing transitions between discrete states
that we analyzed with the iHMM. Left: time series x¯ = (x1, . . . , xN ) of noisy observations. During the measuring
period the biomolecule attains 5 conformations σ1, . . . , σ5. The number of conformations are a priori unknown and the
iHMM seeks to determine the probability over the number of states as well as their properties given the data available. In
dataset 1, the biomolecule transitions often through every state. By contrast, in dataset 2 transitions to some states are
rare. As a result, all states in dataset 1 are almost equally visited throughout the experiment time course, while in dataset
2 higher states are visited, by chance, only toward the end of the trace. Right: corresponding emission distributions Fσk as
obtained by simply binning the observations (blue) and by plotting the exact ones used for the simulations (red). For both
datasets, the emission distributions show significant overlap. In all panels, dotted lines indicate the exact mean values µσk
of the emission distributions.
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Figure 5: After some iterations, the sampler used in the iHMM to analyze dataset 1 of Fig. 4 eventually converges
to the correct number of states. The number of visited states K(r) (top) and the means of the emission distributions
µ
(r)
σk (bottom) change throughout the sampler’s iterations. Unlike the HMM that uses a finite and fixed state space, the
iHMM learns the number of available states and grows/shrinks the state-space as required by the data.
possible choices for the model variables that eventually evolve closer to the ground truth. Once they approach
the ground truth, the sampler begins generating them based on the corresponding posterior distribution P(K|x¯).
So, after burn-in, values with high P(K|x¯) are sampled more often than those with low P(K|x¯).
The same is true of the other variables we try to estimate. For example, in Fig. 5, we also show how the
sampled means of the emission distributions µ(r)σk change through the iterations. As with K(r), during burn-in,
the sampler explores different choices which eventually converge to the ground truth. Afterwords, the sampler
occasionally explores new emissions, for example around iterations 150–250, that quickly disappear.
To obtain more quantitative results, we may drop the burn-in samples from the generated sequences and use
the remainder of the samples to produce histograms. For example, in Fig. 6, we show histograms of K(r) and
µ
(r)
σk . These histograms approximate the corresponding posterior probability distributions and thus provide a full
characterization of the estimated variables. In these cases, the breadth of the histograms arises because the data
we analyze are limited and noisy, so the estimates are associated with some uncertainty that is reflected in the
broadening of the posterior distributions.
As can be seen, dataset 1 – while containing a large number of states which are not well separated – can be
successfully analyzed by means of the iHMM. However, dataset 2 poses another difficulty. Namely, the biomolecule
visits some states only rarely. In experiments, this would give rise to traces with an unequal number of states.
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Figure 6: We may use samples from the iHMM posterior probability to infer the size of the state space and the
location of each state. In particular, we illustrate histograms for P(K|x¯) (top) and P(µσk |x¯) (bottom) using the dataset
1 of Fig. 4. On both panels dashed lines indicate the exact (ground truth) values used to produce the data in Fig. 4.
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Figure 7: We may use the iHMM to estimate portions of the complete state space such as those contained in
different segments of dataset 2 provided in Fig. 4. Upper: shows estimated noiseless traces for two cases: i) using a
limited segment of the full trace; and ii) using the full trace. Although only the later case allows an estimate of all 5 states,
both cases provide similar estimates over those states which they mutually visit. Lower: Corresponding estimates of the
number of states contained in each trace.
One may naively suggest that longer traces should be collected but, due to experimental limitations (e.g. early
photobleaching in FRET experiments), such long traces might not always be available. Instead, a large number
of shorter traces, each containing an unknown portion of the complete state space, may need to be analyzed
separately and the results combined [39]. For this reason, it is crucial to treat all traces on an equal footing
without a priori assuming a different number of states individually for each one as the HMM would require.
To illustrate how the iHMM handles such cases, we use the iHMM to analyze the data of Fig. 4 (bottom
trace) twice. First, using only the initial 300 time steps which visits only 2 out of the 5 states, and subsequently
using the complete trace which contains all 5 states.
Figure 7 shows the results of the analyses. Specifically, in the upper panel we show the estimated noiseless
traces and in the lower panel the estimated numbers of states. As can be seen, the iHMM successfully estimates
the correct number in each trace. Further, as can be seen from the denoised traces, the portion of the state
space, i.e. states σ1 and σ2, that is common is estimated accurately from both traces.
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4 Perspectives
In this survey we presented the infinite hidden Markov model [19, 20], a relatively recent development in Statistics
which has already found diverse applicability, among other fields, in Genomics [40], Genetics [41], Finance [42, 43],
Tracking [44, 45], Machine learning [46, 47], and also Biophysics [22, 23, 24].
As a modeling tool, the iHMM inherits the characteristics of its predecessor – the finite hidden Markov model
– but offers greater flexibility in the modeling and analysis of the experimental data. An important advantage
is that it does not require the underlying system to have a limited state space as would its predecessor. This
feature is of particular importance to Biophysics where little information is often available to fix the number of
biomolecular states a priori.
Despite the difficulty in prespecifying the complexity of the state space, the finite HMM is a routine choice
for the analysis of single molecule time series [11, 12, 13]. Nevertheless, as the experimental techniques improve
and data from complex biomolecules are becoming available, the shortcomings of the finite HMM have become
more apparent. To this end, methods to circumvent the limitations of HMM have been developed independently
of the progress made on the same problems that have exploited Bayesian nonparametrics.
While it has previously been suggested that single molecule analysis may benefit from Bayesian nonparamet-
rics [22], to date only limited applications of these methods have yet been explored. This is, in part, because
models like the iHMM and its implementation are scattered over various sources but also because of the important
language barrier between fields where Bayesian nonparametrics have changed the course of data analysis and the
Physical Sciences. It is in part for this reason that we believe methods continue to be developed to address
consequences of the finiteness of the state space of the HMM in the Physical Sciences.
The iHMM, described here, presents great advantages in the analysis of single molecule observations. For one,
it elegantly addresses those challenges that are presented by the HMM, namely the problem of having to select
a number of states when the emission distributions are unclear. But also, to address the problem – currently
often addressed in a user-dependent fashion – of how to proceed when different traces present a seemingly
different number of states. The key idea is that, just as the HMM performs de-noising while parametrizing
transition kinetics, the iHMM takes this logic one step further by additionally learning the number of states in a
self-consistent manner.
While greatly advantageous, the iHMM itself presents an important challenge for experimental data with drift,
a common feature of Biophysical time traces [26, 13]. Indeed without its explicit consideration, drift would be
interpreted as the population of artifact states by a method willing to recruit extra states to accommodate the
data. This is a key challenge that has so far not been considered anywhere. Without careful consideration, drift
would render the power of the iHMM into a key disadvantage. While our main emphasis here has been to feature
the power of the iHMM to Biophysics, our companion Research article [38] now tackles the problem of extending
iHMMs to deal with drift.
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